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Patient and setting
This study was conducted in a 2999 bedded tertiary care teaching hospital in South India. All consecutive patients positive for Brucella species in blood or body fluid culture from January 2009 to July 2015 were included in this study. Review of the patient data was done (including baseline demography, exposure history and clinical presentation, laboratory investigations, imaging findings, treatment administered and follow-up) and documented in a predetermined pro forma. A diagnosis of brucellosis was made when a patient with prolonged fever with clinical suspicion of brucellosis had automated blood culture positive and other causes of prolonged fever excluded.
Case definitions
Cases were divided into three groups based on the duration of clinical symptoms: acute brucellosis (<2 months), subacute brucellosis (2-12 months) and chronic brucellosis (more than 12 months). [12] Focal form or complication in a patient with active brucellosis was defined based on the clinical features of infection at a particular anatomical site such as bone and joints, genitourinary, neurological, cardiac and pulmonary. 'Relapse' was defined as the reappearance of symptoms with a positive blood or body fluid culture after completion of treatment. The antibiotic combination which the patients received including aminoglycoside, doxycycline and rifampicin were documented.
Ethical approval and funding
This retrospective study protocol was approved by the Institutional Ethics Review Board (Minutes No. 9714) Christian Medical College, Vellore, India. This study collected data from our database and the information collected were anonymised. Our Institutional Review Board and Ethics Committee reviewed the proposal and the consenting process was waived. Hence, no consent was obtained.
Statistical aspects
Statistical analysis was done using Statistical Package for Social Sciences for Windows (SPSS Inc. Released 2007, version 16.0. Chicago). Descriptive statistics were obtained for all study variables. The data were expressed as mean (±standard deviation) and frequency (%).
rEsults
A total of 22 patients with culture-confirmed brucellosis were included in the study of which 21 (95%) were male with a mean age of 42 years. Thirteen (59%) were from rural area. Six (27%) patients had underlying type 2 diabetes mellitus. Sixteen (73%) patients had a significant risk of acquisition of brucellosis with occupational exposure to livestock, such as shepherds or butchers in 11 patients and consumption of unpasteurised milk in five patients. Bacteremia with no definite focus was the most common presentation seen in 18 (82%) patients followed by osteoarticular involvement in 2 (9%) patients, while 1 (4.5%) patient each had genital involvement and endocarditis. Based on the duration of illness, 14 patients (63.6%) were classified as acute and eight patients (36.4%) as subacute brucellosis. The mean duration of symptoms before presentation was 54.5 ± 51.9 days. Characteristics of the patients with culture-confirmed brucellosis are summarised in the Table I . Fever, myalgia, low back pain, sweating, cough, fatigue, vomiting and headache were the symptoms seen in these patients. However, none had proven neurological involvement or pneumonia. All patients had culture-confirmed brucellosis with Brucella melitensis growing in the blood culture for 21 patients and the joint fluid growing the same organism in one patient. Antibiotic susceptibility data showed 20 out of 22 isololates (95%) were susceptible to doxycycline and co-trimoxazole. Streptomycin/gentamicin were susceptible in all ten patients for whom susceptibility was available. Culture from two patients had shown resistance to rifampicin. Serological tests were done for ten patients out of whom two patients had a negative result even though the duration of illness was more than 2 months (subacute presentation). The remaining eight patients had significant titres of serum agglutination test (SAT ≥1:160) with titers as high as 1:1280. Aminoglycoside (streptomycin 1 g intramuscularly once daily for 2 weeks) and doxycycline (100 mg per oral twice daily for 6 weeks) combination therapy was used in 16 patients (72.7%). Additional treatment with rifampicin (15 mg/kg once daily per oral) was used in 3 of these patients. Combination therapy with doxycycline and rifampicin or aminoglycoside and rifampicin was used in three patients (13.6%). Three patients were lost to follow-up and their treatment and outcome were not available. Patients with uncomplicated brucellosis were treated for a total duration of 6 weeks. Patients with endocarditis and osteoarticular involvement were treated for 3 and 6 months, respectively. None of the patients who were followed up had relapse or poor outcome during follow-up period of 18 ± 9 months after completion of therapy.
DiscussiOn
Brucellosis is a disease grossly underrecognised despite its endemicity in India due to low index of suspicion, non-specific clinical manifestations and poor diagnostic facilities. In our case series, there was preponderance of young males (mean age 42 years) similar to previously reports. [4, 12] Most patients had symptoms for <2 months before seeking of medical attention. The most common symptoms include fever, myalgia, low back pain, sweating, cough, fatigue, vomiting and headache. Exposure to livestock was significant with 30% of patients had history of consumption of unpasteurised milk or milk products. Brucella melitensis was the sole isolate from all patients in our study and was consistent with previous reports. [13] Most strains were susceptible to doxycycline and co-trimoxazole with only two isolates showing resistance to rifampicin. Aminoglycoside for the first 2 weeks plus doxycycline for a total duration of 6 weeks was the most common regimen used in our study and none among them had relapse of infection.
Due to the non-specific clinical manifestations and commonality of symptoms with other diseases such as tuberculosis, diagnosis of brucellosis remains a challenge. [14] Hence, awareness of a history of contact with livestock or food habits such as consumption of unpasteurised milk is important in raising a suspicion of brucellosis. Furthermore, the importance of a good laboratory for establishing the diagnosis cannot be stressed enough. Increase in blood culture yield in our institution in the recent years is probably due to the use of automated blood culture and identification systems which is known to be more efficient than traditional bacterial culture methods in the isolation of Brucella as previously reported. [11, 15, 16] However, the sensitivity of the blood culture method varies between 15% and 70% due to which the use of serological tests for diagnosis becomes necessary particularly in chronic disease. [17] The standard tube agglutination test is the most widely used serological test for diagnosis of brucellosis. A fourfold rise in titre or a titre of more than 1:160 is significant except in endemic regions where a titre higher than 1: 320 is considered significant. Amplification of bacterial DNA from involved tissue by polymerase chain reaction has a high sensitivity and specificity of 100% and 98.3% reported if appropriate sample is used. [18] The antibiotic treatment recommendation is based on best cure rates and low relapse of infection. The World Health Organization guidelines recommend a combination of oral doxycycline 100 mg twice daily for 6 weeks and intramuscular streptomycin 1 g once daily for 3 weeks or oral doxycycline 100 mg twice daily and oral rifampicin 15 mg/kg once daily for a total duration of 6 weeks for uncomplicated brucellosis. [19] A Cochrane review recommended a regimen consisting of doxycycline for 6 weeks along with streptomycin for 2-3 weeks was more effective than one consisting of doxycycline with rifampicin for 6 weeks for uncomplicated brucellosis. [20] The commonly used regimen in this series of doxycycline for a total duration of 6 weeks along with aminoglycoside for the first 2 weeks was found to be effective in achieving both objectives of treatment. Rifampicin was not prescribed in most of our patients due to the high endemicity of tuberculosis in India apart from the fact that the current evidence suggests that a combination of aminoglycoside and doxycycline is highly efficacious. A triple regimen of doxycycline, aminoglycoside and rifampicin is sometimes recommended for complicated infection, but our single case of endocarditis was successfully treated with initial 2 weeks of aminoglycoside along with doxycycline for 6 months. The previously reported relapse rate varied between 5% and 40% depending on the drug combination and treatment duration. [12, 21] It was more common in patients with osteoarticular involvement. The main limitation of this study is its retrospective nature and absence of long-term follow up of patients. However, our study is one of the few reports from India which reflects the true clinical spectrum and outcome in patients with culture-confirmed brucellosis.
cOnclusiOn
Brucellosis is an underrecognised zoonosis in India. Fever with constitutional symptoms, arthralgia and hepatosplenomegaly along with high clinical suspicion based on the history of exposure should alert the clinician to consider the diagnosis of brucellosis. Automated blood culture systems improve the diagnostic yield. Treatment with doxycycline and an aminoglycoside leads to favourable outcome.
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